TGFB1 and liver dysplastic nodule: An albumin-bound nanoformulation, nab-paclitaxel has partially ameliorated the microscopic structural changes encountered in the renal cortex during DN, and decreased the immune expression of the fibrogenic mediator TGF-β1 to exert renoprotective effects (95).